周一“星”视角|将呼吸性肌减症的诊断应用于非小细胞肺癌术后风险分层；淋巴血管侵犯对存在磨玻璃影情况的I期肺腺癌的预后价值

文章预览

本期胸小星将为大家带来 将呼吸性肌减症的诊断应用于非小细胞肺癌术后风险分层 ； 淋巴血管侵犯对存在磨玻璃影情况的I期肺腺癌的预后价值 ，一起来看看吧！ 2017·EATTS  01 Diagnosis of Respiratory Sarcopenia for Stratifying Postoperative Risk in Non-Small Cell Lung Cancer Changbo Sun1 2, Yoshifumi Hirata3, Takuya Kawahara4, Mitsuaki Kawashima2, Masaaki Sato2, Jun Nakajima2, Masaki Anraku2. 1 Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. 2 Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. 3 Department of Thoracic and Thyroid Surgery, Kyorin University School of Medicine, Tokyo, Japan. 4 Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan. Background:   Physical biomarkers for stratifying patients with lung cancer into subtypes suggestive of outcomes are underexplored. Objective: ………………………………